How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. Are your ears under assault? In today’s world, it ...

Supply chains are messy. San Francisco-based startup Loop isn’t content helping companies merely clean up their supply chains. Instead, the startup is using AI to offer companies predictive, and even ...

The founder of PocketOS said that a Cursor AI agent running on Anthropic's Claude Opus model was behind the "destructive ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

RXRX is trading near the bottom of its 52-week range and below its 200-day simple moving average. Price change The price of RXRX shares has decreased $0.16 since the market last closed. This is a 4.66 ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

We’re unpacking the headlines and making the news make sense. Get connected with local experts, your neighbors and the stories shaping Chicago. May 6, 2026 • New pay-to-park barriers are popping up at ...